Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
ill; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of illness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced illness (Verbatim: ill). The outcome of the illness was resolving. It was unknown if the reporter considered the illness to be related to Shingles vaccine. It was unknown if the company considered the illness to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 26-JAN-2026 This case was reported by a patient via interactive digital media. The patient was really ill after the first shot but felt little to no side effects after the second shot. Patient said feel better after 2 to 3 days. The batch number was not provided and unable to contact the reporter.